Catholic Relief Services said May 21 that most of its projects under a federal international food aid program were terminated, leaving hundreds of thousands of children more v ...

Lyra Therapeutics (NASDAQ:LYRA) saw its stock soar by 180% after releasing encouraging Phase 3 results for its lead ...

Most CRS, ICANS, and neuro events after liso-cel were mild and occurred within 15 days post-infusion, according to different ...

It made me feel good, of course, to be associated with the project that was where children weren’t dying,” said CRS’ Bill ...

Tennis anyone? How about pickleball? Just in time for summer, the new tennis and pickleball courts behind Avon Lake High ...

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

The May 28, 2025 Congressional Research Service report discusses Russia's military performance during its invasion of Ukraine.

He brings not only a results-oriented mindset but also a deep appreciation for the impact of recreation.” — Ron Romens, Founder of CRS VERONA, WI, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- ...

SpaceX’s Falcon 9 rocket left Space Launch Complex 40 at Cape Canaveral Space Force Station at 4:55 p.m. ET to send CRS-30 mission to the ISS. The 45th Weather Squadron gave a 90% chance of good ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

J&J has a multi-year head start, but Gilead believes it can win market share by delivering a drug with better safety and at ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...